RNAi Therapeutics: To the Liver ... and Beyond
RNAi Therapy Components Are Surviving Degradation, Staying Potent, and Reaching More Targets Than Ever
Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Flip the DNA Nanoswitch, Power the Clinical App
A Molecular Interaction Detection Platform Uses a Gel-based Readout
The Top 15 Best-Selling Drugs of 2017
Amid Talk of Curbing Prices, Most Treatments Show Sales Gains
Christoper T. Eggers, Ph.D.
Christopher T. Eggers, Ph.D., is a senior research scientist at Promega.
More GEN Content From This Contributor
- Tutorials: Protein Stability Exposes Cellular Stress
- Feature Articles: Advertorial: Quantitate Protein Abundance at Endogenous Levels